Abstract
Escherichia coli O157:H7 is a significant human pathogen that is continually responsible for sickness, and even death, on a worldwide scale. While the pathology of E. coli O157:H7 infection has been well studied, the effect of it’s multiple resulting cytotoxic mechanisms on host metabolic activity has not been well characterized. To develop a more thorough understanding of these effects, several bioluminescence assays were evaluated for their ability to track both toxicity and host metabolic activity levels in real-time. The use of continuously autobioluminescent human cells was determined to be the most favorable method for tracking these metrics, as its self-sufficient autobioluminescent phenotype was unaffected by the presence of the infecting bacteria and its signal could be measured without cellular destruction. Using this approach, it was determined that infection with as few as 10 CFU of E. coli O157:H7 could elicit cytotoxic effects. Regardless of the initial infective dose, an impact on metabolic expression was not observed until bacterial populations reached levels between 5 × 105 and 1 × 106 (R2 = 0.933), indicating that a critical bacterial infection level must be reached prior to the onset of cytotoxic effects. Supporting this hypothesis, it was found that cells displaying infection-mediated metabolic activity reductions could recover to wild type metabolic activity levels if the infecting bacteria were removed prior to cell death. These results indicate that rapid treatment of E. coli O157:H7 infection could serve to limit host metabolic impact and reduce overall host cell death.
Similar content being viewed by others
References
Bitzan MM, Wang Y, Lin J et al (1998) Verotoxin and ricin have novel effects on preproendothelin-1 expression but fail to modify nitric oxide synthase (ecNOS) expression and NO production in vascular endothelium. J Clin Invest 101:372–382
Brunder W, Schmidt H, Karch H (1996) KatP, a novel catalase-peroxidase encoded by the large plasmid of enterohaemorrhagic Escherichia coli O157: H7. Microbiology 142:3305–3315
Class B, Thorne N, Aguisanda F et al (2014) High-throughput viability assay using an autonomously bioluminescent cell line with a bacterial lux reporter. J Lab Autom. doi:10.1177/2211068214560608
Close D, Xu T, Sayler GS et al (2010) In vivo bioluminescent imaging (BLI): noninvasive visualization and interrogation of biological processes in living animals. Sensors 11:180–206
Karch H, Tarr PI, Bielaszewska M (2005) Enterohaemorrhagic Escherichia coli in human medicine. Int J Med Microbiol 295:405–418
Klein EJ, Stapp JR, Clausen CR et al (2002) Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study. J Pediatr 141:172–177
Law D (2000) The history and evolution of Escherichia coli O157 and other Shiga toxin-producing E. coli. World J Microbiol Biotechnol 16:701–709
Lukyanenko V, Malyukova I, Hubbard A et al (2011) Enterohemorrhagic Escherichia coli infection stimulates Shiga toxin 1 macropinocytosis and transcytosis across intestinal epithelial cells. Am J Physiol Cell Physiol 301:C1140–C1149
Murray JI, Whitfield ML, Trinklein ND et al (2004) Diverse and specific gene expression responses to stresses in cultured human cells. Mol Biol Cell 15:2361–2374
Nataro JP, Kaper JB (1998) Diarrheagenic Escherichia coli. Clin Microbiol Rev 11:142–201
Pace DA, Manahan DT (2007) Cost of protein synthesis and energy allocation during development of antarctic sea urchin embryos and larvae. Biol Bull 212:115–129
Sandvig K, Bergan J, Dyve AB et al (2010) Endocytosis and retrograde transport of Shiga toxin. Toxicon 56:1181–1185
Tarr PI, Neill MA, Clausen CR et al (1990) Escherichia coli O157:H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology. J Infect Dis 162:553–556
Valderrama WB, Dudley EG, Doores S et al (2015) Commercially available rapid methods for detection of selected foodborne pathogens. Crit Rev Food Sci Nutr. doi:10.1080/10408398.10402013.10775567
Xu T, Ripp S, Sayler G et al (2014) Expression of a humanized viral 2A-mediated lux operon efficiently generates autonomous bioluminescence in human cells. PLoS One 9:e96347
Acknowledgments
Funding support for this work was provided to the University of Tennessee by the National Science Foundation Division of Chemical, Bioengineering, Environmental, and Transport Systems (CBET) under award number CBET-0853780.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Xu, T., Marr, E., Lam, H. et al. Real-time toxicity and metabolic activity tracking of human cells exposed to Escherichia coli O157:H7 in a mixed consortia. Ecotoxicology 24, 2133–2140 (2015). https://doi.org/10.1007/s10646-015-1552-3
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10646-015-1552-3